A phase II study of leucovorin (LV)-modulated continuous infusion (CI) fluorouracil (DU) + CPT-11 alternating with LV-modulated CI FU + Oxaliplatin (L-OHP) in advanced colorectal cancer (CCR): high activity and low toxicity